DarioHealth Corp expected to post a loss of 76 cents a share - Earnings Preview

DarioHealth

12/11/2022 02:54

* DarioHealth Corp  DRIO.OQ   DRIO.O  is expected to show a
rise
in quarterly revenue when it reports  results on November 14. 
    * The New York City-based  company is expected to report  a
10.7% increase in revenue to $6.232 million from $5.63 million a
year ago, according to the mean estimate from 5 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for DarioHealth Corp is
for a
loss of 76 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for DarioHealth
Corp
is $14​, above​ its last closing price of $4.08. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.71       -0.71      -0.74     Missed  -3.9
 Mar. 31 2022  -0.96       -0.96      -0.74     Beat    22.7
 Dec. 31 2021  -1.09       -1.06      -1.09     Missed  -3.2​
 Sep. 30 2021  -0.91       -0.94      -1.18     Missed  -26.1
 ​​Jun.        -0.87       -0.85      -0.99     Missed  -15.8
 30 2021                                                
 Mar. 31 2021  -1.18       -1.04      -0.92     Beat    11.7​
 Dec. 31 2020  -0.77       -0.81      -1.06     Missed  -30.5
 Sep. 30 2020  -0.68       -0.68      -0.71     Missed  -3.9
 This summary was machine generated November 12 at 02:54 GMT. 
All figures in US dollars  unless otherwise stated